Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
Authors
Keywords
-
Journal
OncoImmunology
Volume 4, Issue 8, Pages e970462
Publisher
Informa UK Limited
Online
2014-10-31
DOI
10.4161/21624011.2014.970462
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Few Foxp3+regulatory T cells are sufficient to protect adult mice from lethal autoimmunity
- (2014) Christian T. Mayer et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Decreased Pathology and Prolonged Survival of Human DC-SIGN Transgenic Mice during Mycobacterial Infection
- (2014) M. Schaefer et al. JOURNAL OF IMMUNOLOGY
- Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg
- (2013) A. S. Baur et al. BLOOD
- The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trials
- (2013) Sebastian P Haen et al. CURRENT OPINION IN IMMUNOLOGY
- In vivo targeting of human DC-SIGN drastically enhances CD8+T-cell-mediated protective immunity
- (2013) Christina Hesse et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy
- (2013) Paula D. Bos et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The physiological role of DC-SIGN: A tale of mice and men
- (2013) Juan J. Garcia-Vallejo et al. TRENDS IN IMMUNOLOGY
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells
- (2012) Wendy W.J. Unger et al. JOURNAL OF CONTROLLED RELEASE
- Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells
- (2012) Juan J. García-Vallejo et al. MOLECULAR IMMUNOLOGY
- Targeting regulatory T cells
- (2012) Christine Ménétrier-Caux et al. Targeted Oncology
- Targeting Dendritic Cells in vivo for Cancer Therapy
- (2012) Irina Caminschi et al. Frontiers in Immunology
- Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity
- (2012) Christian T. Mayer et al. Frontiers in Immunology
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
- (2011) Daniel T. Fisher et al. JOURNAL OF CLINICAL INVESTIGATION
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
- (2010) R. Bos et al. CANCER RESEARCH
- Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
- (2010) K. Klages et al. CANCER RESEARCH
- Analysis of the T-Cell Receptor Repertoires of Tumor-Infiltrating Conventional and Regulatory T Cells Reveals No Evidence for Conversion in Carcinogen-Induced Tumors
- (2010) J. P. Hindley et al. CANCER RESEARCH
- Conditional Regulatory T-Cell Depletion Releases Adaptive Immunity Preventing Carcinogenesis and Suppressing Established Tumor Growth
- (2010) M. W. L. Teng et al. CANCER RESEARCH
- Efficient Treg depletion induces T-cell infiltration and rejection of large tumors
- (2010) Xingrui Li et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Regulatory T cells in tumor immunity
- (2010) Hiroyoshi Nishikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro
- (2010) Luis J. Cruz et al. JOURNAL OF CONTROLLED RELEASE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
- (2009) I. Kryczek et al. CANCER RESEARCH
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation
- (2009) Satwinder Kaur Singh et al. MOLECULAR IMMUNOLOGY
- Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
- (2008) M. A. Morse et al. BLOOD
- Tuning Microenvironments: Induction of Regulatory T Cells by Dendritic Cells
- (2008) Yasmine Belkaid et al. IMMUNITY
- Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma
- (2008) Jeffrey A. Sosman et al. JOURNAL OF CLINICAL ONCOLOGY
- Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
- (2008) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Engineered lentivector targeting of dendritic cells for in vivo immunization
- (2008) Lili Yang et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now